Trait centric view

1. Trait name:	Average daily gain
   Ontology terms:	VT:0001731, CMO:0000419

   125 genes are associated with this trait, with QTL/association found

   • ACSS2L: Acyl-CoA synthetase short chain family member 2 like
     evidenced by: QTL:213964; QTL:213965;
   • BLOC1S2: Biogenesis of lysosomal organelles complex-1, subunit 2
     evidenced by: QTL:213958; QTL:213959; QTL:213960; QTL:213961; QTL:213962; QTL:213963;
   • BTK: Bruton tyrosine kinase
     evidenced by: QTL:214118;
   • C2H12ORF29: Chromosome 2 C12orf29 homolog
     evidenced by: QTL:213906;
   • CAV1: Caveolin 1
     evidenced by: QTL:213897; QTL:213898; QTL:213899; QTL:213900; QTL:213901; QTL:213902;
   • CLSTN1: Calsyntenin 1
     evidenced by: QTL:214147;
   • CPA5: Carboxypeptidase A5
     evidenced by: QTL:213905;
   • CPB2: Carboxypeptidase B2
     evidenced by: QTL:214123; QTL:214124;
   • EIF4G2B: Eukaryotic translation initiation factor 4, gamma 2b
     evidenced by: QTL:213907; QTL:213908;
   • ELF1: E74-like ETS transcription factor 1
     evidenced by: QTL:214112;
   • ETFDH: Electron transfer flavoprotein dehydrogenase
     evidenced by: QTL:214073; QTL:214074; QTL:214075; QTL:214076;
   • GLA: Galactosidase alpha
     evidenced by: QTL:214115;
   • ITPA: Inosine triphosphatase
     evidenced by: QTL:213933; QTL:213934;
   • JUN: Jun proto-oncogene, AP-1 transcription factor subunit
     evidenced by: QTL:213917;
   • LAMP2: Lysosomal-associated membrane protein 2
     evidenced by: QTL:214096; QTL:214097; QTL:214098; QTL:214099; QTL:214100;
   • LOC110486224: Prohibitin-like
     evidenced by: QTL:214027; QTL:214028; QTL:214029; QTL:214030;
   • LOC110486226: Synaptic vesicle membrane protein VAT-1 homolog
     evidenced by: QTL:214031; QTL:214032; QTL:214150;
   • LOC110486228: Rho-related GTP-binding protein RhoN-like
     evidenced by: QTL:214033;
   • LOC110486230: Methyltransferase-like protein 2-A
     evidenced by: QTL:214034;
   • LOC110486231: Integrin beta-3-like
     evidenced by: QTL:214035;
   • LOC110486234: Telethonin-like
     evidenced by: QTL:214036; QTL:214037; QTL:214038; QTL:214039;
   • LOC110486236: StAR-related lipid transfer protein 3
     evidenced by: QTL:214040; QTL:214041;
   • LOC110486237: Protein phosphatase 1 regulatory subunit 1B-like
     evidenced by: QTL:214042; QTL:214043;
   • LOC110486239: Cyclin-dependent kinase 12-like
     evidenced by: QTL:214044; QTL:214045; QTL:214046; QTL:214047;
   • LOC110486245: Synaptonemal complex protein SC65-like
     evidenced by: QTL:214048; QTL:214049;
   • LOC110486247: Peptidyl-prolyl cis-trans isomerase FKBP10-like
     evidenced by: QTL:214050; QTL:214051; QTL:214052; QTL:214053;
   • LOC110486250: ATP-citrate synthase
     evidenced by: QTL:214056;
   • LOC110486251: 2',3'-cyclic-nucleotide 3'-phosphodiesterase-like
     evidenced by: QTL:214057; QTL:214058; QTL:214059; QTL:214060; QTL:214061; QTL:214062; QTL:214063;
   • LOC110486253: DnaJ homolog subfamily C member 7-like
     evidenced by: QTL:214064; QTL:214065;
   • LOC110486255: NF-kappa-B inhibitor-interacting Ras-like protein 2
     evidenced by: QTL:214066;
   • LOC110486259: Histone acetyltransferase KAT2A-like
     evidenced by: QTL:214067;
   • LOC110486260: Ras-related protein Rab-5C-like
     evidenced by: QTL:214068;
   • LOC110486263: Polymerase I and transcript release factor-like
     evidenced by: QTL:214072; QTL:214151; QTL:214152; QTL:214153; QTL:214154; QTL:214155;
   • LOC110488945: Prominin-1-A-like
     evidenced by: QTL:214080; QTL:214081;
   • LOC110488947: Fibroblast growth factor-binding protein 1-like
     evidenced by: QTL:214082;
   • LOC110488948: Cyclin-A2-like
     evidenced by: QTL:214083;
   • LOC110488950: Transmembrane protein 33-like
     evidenced by: QTL:214084; QTL:214085;
   • LOC110488956: Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha-like
     evidenced by: QTL:214086;
   • LOC110488957: Glutathione S-transferase P-like
     evidenced by: QTL:214087; QTL:214088;
   • LOC110488962: Inositol polyphosphate 5-phosphatase OCRL-1-like
     evidenced by: QTL:214091;
   • LOC110488963: Chloride intracellular channel protein 2-like
     evidenced by: QTL:214092;
   • LOC110488964: C1GALT1-specific chaperone 1-like
     evidenced by: QTL:214093;
   • LOC110488974: 60S ribosomal protein L39-like
     evidenced by: QTL:214107;
   • LOC110488975: Septin-6-like
     evidenced by: QTL:214108; QTL:214109; QTL:214110;
   • LOC110488980: Tenomodulin-like
     evidenced by: QTL:214113; QTL:214114;
   • LOC110488986: 60S ribosomal protein L36a-like
     evidenced by: QTL:214116; QTL:214117;
   • LOC110488989: Magnesium transporter NIPA2-like
     evidenced by: QTL:214119;
   • LOC110488993: Mediator of RNA polymerase II transcription subunit 12-like
     evidenced by: QTL:214120;
   • LOC110488994: Multidrug resistance-associated protein 5-like
     evidenced by: QTL:214121; QTL:214122;
   • LOC110489663: Ligand of Numb protein X 2-like
     evidenced by: QTL:214156;
   • LOC110489750: N/agamma-soluble NSF attachment protein-like
     evidenced by: QTL:214158;
   • LOC110489782: Myosin-7-like
     evidenced by: QTL:214159;
   • LOC110489787: Microtubule-associated protein 4-like
     evidenced by: QTL:214160; QTL:214161; QTL:214162; QTL:214163; QTL:214164; QTL:214165;
   • LOC110489788: Uncharacterized protein DDB_G0284459-like
     evidenced by: QTL:214166;
   • LOC110495923: Basic leucine zipper and W2 domain-containing protein 1-A-like
     evidenced by: QTL:214168;
   • LOC110495957: Protein FAM134A-like
     evidenced by: QTL:214125;
   • LOC110496062: Plectin-like
     evidenced by: QTL:214127; QTL:214128;
   • LOC110496097: Trypsin-3-like
     evidenced by: QTL:214133;
   • LOC110496110: Double-strand-break repair protein rad21 homolog
     evidenced by: QTL:214137; QTL:214138;
   • LOC110499159: Uncharacterized LOC110499159
     evidenced by: QTL:214169;
   • LOC110499430: High choriolytic enzyme 2-like
     evidenced by: QTL:213892;
   • LOC110499482: F-actin-capping protein subunit alpha-2
     evidenced by: QTL:213894; QTL:213895; QTL:213896;
   • LOC110499906: Actin, alpha cardiac muscle 1-like
     evidenced by: QTL:213911; QTL:213912; QTL:213913;
   • LOC110499936: Anoctamin-1-like
     evidenced by: QTL:213914;
   • LOC110499952: G1/S-specific cyclin-D1-like
     evidenced by: QTL:213915; QTL:213916;
   • LOC110502295: Cortactin-binding protein 2-like
     evidenced by: QTL:213893;
   • LOC110502363: Kinesin-like protein KIF21A
     evidenced by: QTL:213910;
   • LOC110508425: Elongation factor 2-like
     evidenced by: QTL:214171;
   • LOC110520091: D-3-phosphoglycerate dehydrogenase-like
     evidenced by: QTL:214139;
   • LOC110521622: Protein PRRC2C-like
     evidenced by: QTL:213923;
   • LOC110521624: Myocilin-like
     evidenced by: QTL:213926; QTL:213927; QTL:213928; QTL:213929; QTL:213930; QTL:213931; QTL:213932;
   • LOC110521628: SUN domain-containing ossification factor-like
     evidenced by: QTL:213936; QTL:213937;
   • LOC110521629: Transmembrane emp24 domain-containing protein 5-like
     evidenced by: QTL:213938; QTL:213939; QTL:213940; QTL:213941;
   • LOC110521630: Histone H2A deubiquitinase MYSM1-like
     evidenced by: QTL:213942;
   • LOC110521632: FYN-binding protein-like
     evidenced by: QTL:213946;
   • LOC110521633: Disabled homolog 1-like
     evidenced by: QTL:213945;
   • LOC110521634: Phospholipid phosphatase 3-like
     evidenced by: QTL:213953; QTL:213954; QTL:213955; QTL:213956; QTL:213957;
   • LOC110529058: Isoleucine--tRNA ligase, cytoplasmic-like
     evidenced by: QTL:214142;
   • LOC110530769: Purine nucleoside phosphorylase-like
     evidenced by: QTL:214143;
   • LOC110530779: Death-associated protein kinase 3-like
     evidenced by: QTL:214144;
   • LOC110530857: NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial-like
     evidenced by: QTL:213966; QTL:213967;
   • LOC110530869: DnaJ homolog subfamily B member 4-like
     evidenced by: QTL:213973;
   • LOC110530874: Acidic leucine-rich nuclear phosphoprotein 32 family member A-like
     evidenced by: QTL:213971;
   • LOC110530875: Putative 60S ribosomal protein L37a
     evidenced by: QTL:213994; QTL:213995;
   • LOC110530878: Elongation factor 1-delta-like
     evidenced by: QTL:213986; QTL:213987; QTL:213988;
   • LOC110530880: Uncharacterized LOC110530880
     evidenced by: QTL:213974; QTL:213975; QTL:213976; QTL:213977; QTL:213978; QTL:213979;
   • LOC110531054: V-type proton ATPase subunit H-like
     evidenced by: QTL:213983; QTL:213984;
   • LOC110531056: Collagen alpha-2(VI) chain-like
     evidenced by: QTL:213999;
   • LOC110531523: Butyrophilin subfamily 1 member A1-like
     evidenced by: QTL:214145;
   • LOC110531846: Glycogen phosphorylase, muscle form-like
     evidenced by: QTL:214001; QTL:214002;
   • LOC110531861: EH domain-binding protein 1-like protein 1
     evidenced by: QTL:214004; QTL:214005; QTL:214006; QTL:214007; QTL:214008; QTL:214009;
   • LOC110531862: EH domain-binding protein 1-like
     evidenced by: QTL:214003;
   • LOC110532102: Acetyl-coenzyme A synthetase, cytoplasmic-like
     evidenced by: QTL:214011;
   • LOC110532103: Microtubule-associated protein RP/EB family member 1-like
     evidenced by: QTL:214012;
   • LOC110532120: Protein RCC2 homolog
     evidenced by: QTL:214016; QTL:214017;
   • LOC110532123: Short-chain dehydrogenase/reductase 3-like
     evidenced by: QTL:214018; QTL:214019;
   • LOC110532146: Sodium-coupled neutral amino acid transporter 3-like
     evidenced by: QTL:214026;
   • LOC110537518: Nucleolar protein 16-like
     evidenced by: QTL:214149;
   • MCTS1: MCTS1 re-initiation and release factor
     evidenced by: QTL:214094; QTL:214095;
   • MMP30: Matrix metallopeptidase 30
     evidenced by: QTL:214148;
   • NDUFB3: NADH:ubiquinone oxidoreductase subunit B3
     evidenced by: QTL:213989;
   • NEU1: Neuraminidase 1
     evidenced by: QTL:214136;
   • OLAH: Oleoyl-ACP hydrolase
     evidenced by: QTL:214131;
   • OMA1: OMA1 zinc metallopeptidase
     evidenced by: QTL:213943;
   • ORC2: Origin recognition complex, subunit 2
     evidenced by: QTL:213996;
   • PECR: Peroxisomal trans-2-enoyl-CoA reductase
     evidenced by: QTL:213990;
   • PIGC: Phosphatidylinositol glycan anchor biosynthesis, class C
     evidenced by: QTL:213935;
   • PLPP6: Phospholipid phosphatase 6
     evidenced by: QTL:213921;
   • PPID: Peptidylprolyl isomerase D
     evidenced by: QTL:214077;
   • PRDX6: Peroxiredoxin 6
     evidenced by: QTL:213918; QTL:213919; QTL:213920;
   • PRKAA2: Protein kinase, AMP-activated, alpha 2 catalytic subunit
     evidenced by: QTL:213949; QTL:213950; QTL:213951;
   • PRKAG3A: Protein kinase, AMP-activated, gamma 3a non-catalytic subunit
     evidenced by: QTL:214126;
   • RALBP1: RalA binding protein 1
     evidenced by: QTL:213980; QTL:213981;
   • RAPGEF2: Rap guanine nucleotide exchange factor (GEF) 2
     evidenced by: QTL:214078;
   • RBTSTAT3: Stat3
     evidenced by: QTL:214070; QTL:214071;
   • RL21: 60S ribosomal protein L21
     evidenced by: QTL:214157;
   • RNF207B: Ring finger protein 207b
     evidenced by: QTL:214014;
   • SLC6A15: Solute carrier family 6 member 15
     evidenced by: QTL:213909;
   • TES: Testis derived transcript (3 LIM domains)
     evidenced by: QTL:213903; QTL:213904;
   • THBS1B: Thrombospondin 1b
     evidenced by: QTL:214140;
   • TMEM255A: Transmembrane protein 255A
     evidenced by: QTL:214101; QTL:214102; QTL:214103; QTL:214104;
   • TPX2: TPX2 microtubule nucleation factor
     evidenced by: QTL:214020;
   • UPF3B: UPF3B regulator of nonsense mediated mRNA decay
     evidenced by: QTL:214105; QTL:214106;
   • VAMP4: Vesicle associated membrane protein 4
     evidenced by: QTL:213924;
   • ZGC:162816: Uncharacterized LOC110530868
     evidenced by: QTL:213997; QTL:213998;